Glutamate Receptor GluR3 Antibodies and Death of Cortical Cells  by He, Xiao-Ping et al.
Neuron, Vol. 20, 153±163, January, 1998, Copyright 1998 by Cell Press
Glutamate Receptor GluR3 Antibodies
and Death of Cortical Cells
gliosis. Because the epileptic seizures are often unre-
sponsive to conventional antiseizure drugs, surgical
removal of the involved hemisphere is the standard ther-
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Recent discoveries have demonstrated that RE is anDivision of Neurology
Department of Medicine autoimmune disease in which one of the autoantigens
is a glutamate receptor of the a-amino-3-hydroxy-5-Duke University Medical Center
²Departments of Neurobiology and Pharmacology methyl-isoxazole-4-propionicacid (AMPA)subtype,GluR3
(Rogers et al., 1994). The occurrence of epileptic sei-Duke University Medical Center
Durham, North Carolina 27710 zures and inflammatory histopathology in two rabbits
immunized with a GluR3 fusion protein led to the discov-Durham Veterans Affairs Medical Center
Durham, North Carolina 27705 ery of circulating anti-GluR3 antibodies in patients with
active RE. The responsiveness of several patients to³Department of Molecular Biology and Biochemistry
University of California plasma exchange that removed circulating anti-GluR3
antibodies suggested that the anti-GluR3 gained accessIrvine, California 92697
to the central nervous system and contributed to the
neuronal degeneration (Rogers et al., 1994; Andrews et
al., 1996). Anti-GluR3 antibodies isolated from ill TrpE±Summary
GluR3-immunized rabbits and patients with RE were
found to have agonist properties at the AMPA subtypeRasmussen's encephalitis (RE), a childhood disease
of glutamate receptor in mouse cortical neurons (Twy-characterized by epileptic seizures associated with
man et al., 1995). Since excessive activation of gluta-progressive destruction of a single cerebral hemi-
mate receptors can destroy cortical neurons through ansphere, is an autoimmune disease in which one of
excitotoxic mechanism (Choi, 1988), it seemed plausiblethe autoantigens is a glutamate receptor, GluR3. The
that circulating anti-GluR3 antibodiescould induce exci-improvement of some affected children following
totoxic injury.plasma exchange that removed circulating GluR3 anti-
The goal of this work was to determine whether cir-bodies (anti-GluR3) suggested that anti-GluR3 gained
culating anti-GluR3 antibodies destroyed cortical cellsaccess to the central nervous system where it exerted
and if so, by what mechanism. Here, we confirm anddeleterious effects. Here, we demonstrate that a sub-
extend our initial findings by demonstrating that a subsetset of rabbits immunized with a GluR3 fusion protein
of rabbits immunized with a GluR3 fusion protein devel-develops a neurological disorder mimicking RE. Anti-
ops a neurological disorder that includes epileptic sei-GluR3 IgG isolated from serum of both ill and healthy
zures and inflammatory histopathology. Anti-GluR3 anti-GluR3-immunized animals promoted death of cultured
bodies isolated from GluR3-immunized rabbits promotecortical cells by a complement-dependent mecha-
destruction of cortical cells in vitro by a complement-nism. IgG immunoreactivity decorated neurons and
dependent, but not excitotoxic, mechanism. The subsettheir processes in neocortex and hippocampus in ill
of GluR3-immunized rabbits with the neurological disor-but not in healthy rabbits. Moreover, both IgG and
der exhibits abundant IgG immunoreactive-labeling ofcomplement membrane attack complex (MAC) immu-
neurons and their processes in neocortex and hippo-noreactivity was evident on neurons and their pro-
campus. The findings in the rabbit model led to studiescesses in thecortex of a subset of patients with RE. We
of human tissue in which IgG and MAC-like immunoreac-suggest that access of IgG to epitopes in the central
tive labeling of neurons and their processes was discov-nervous system triggers complement-mediated neu-
ered in the cortex of a subset of humans with RE.ronal damage and contributes to the pathogenesis of
both this animal model and RE.
Results
Introduction
Repeated immunization with a glutathione-S-trans-
ferase GluR3 (GST±GluR3) fusion protein was associ-Rasmussen's encephalitis (RE) is a rare disease charac-
ated with a distinctive neurological disorder in two of fiveterized by progressive destruction of a single cerebral
rabbits. Each of the two rabbits was alert yet exhibitedhemisphere (Rasmussen et al., 1958). The disease typi-
motor incoordination while ambulating either in an opencally begins in the first decade of life and is manifested
space or in a cage. This defective motor control oc-by severe seizures and progressive loss of functions
curred in the absence of detectable weakness of hind-subserved by the involved hemisphere. The underlying
limbs or forelimbs. Responsiveness to crude sensoryhistopathology consists of perivascular lymphocytic
stimuli such as an air puff to the face or gentle pinchingcuffing, microglial nodules, neuronal destruction, and
of extremities was intact. In addition, each rabbit exhib-
ited occasional epileptic seizures manifested as repeti-
tive tonic and/or clonic movements of all four extremities§These authors contributed equally to this work.
‖ To whom correspondence should be addressed. lasting z20±40 s; in one animal, the repetitive clonic
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movements were immediately preceded by head nod-
ding associated with unresponsiveness, behaviors char-
acteristic of complex partial seizures. The epileptic sei-
zures were followed by obtundation for several minutes
prior to resumption of normal activities. The onset of
this illness occurred 2 weeks after the second immuniza-
tion in one animal and 3 days after the third immunization
in the other. Each animal exhibited reduced food and
water intake and lost z25% of its body weight. Persis-
tent obtundation together with weight loss eventually
necessitated sacrificing both of these rabbits. No illness
was evident in three other rabbits despite five to seven
immunizations with GST±GluR3 over several months.
Likewise, no illness was found in seven rabbits receiving
multiple immunizations with GST nor in two rabbits re-
ceiving no immunizations. Inspection of hematoxylin-
and eosin-stained sections revealed mononuclear cell
infiltrates in circumscribed regions of cerebral cortex
and surrounding blood vessels in the cortex of both
cerebral hemispheres of the two sick rabbits but in none
of the other twelve rabbits (data not shown), confirming
our previous observations (Rogers et al., 1994).
To determine whether constituents of blood of the
GST±GluR3-immunized rabbits might damage cortical
cells, filtrates of plasma or serum were incubated with
Figure 1. Cytotoxicity of Plasma Filtrates of GST±GluR3-Immunizedrat cortical cultures containing mixtures of neurons and
Rabbitsglia. Following Sephadex G-50 chromatography to re-
(A) Protein isolated from serum or plasma of GST±GluR3-immunizedmove low molecular weight substances such as gluta-
rabbits induces release of LDH from cultures of mixed neuronsmate, the higher molecular weight fraction (ªfiltrateº)
and glia in a concentration-dependent manner. The plot shows the
was incubated with mixed neuronal-glial cultures for 24 mean 6 SEM of LDH released following 24 hr exposure of cortical
hr, and cell death was quantitated by measurement of cells to varying concentrations of serum or plasma collected from
lactate dehydrogenase (LDH) in the media. Plasma or five GST±GluR3-immunized andnine control (seven GST-immunized
and two nonimmunized) rabbits (3±6 wells/animal). Data were ana-serum filtrates isolated from two sick and two of three
lyzed by one-way analysis of variance (ANOVA) followed by posthealthy GST±GluR3-immunized rabbits destroyed corti-
hoc Tukey-Kramer multiple comparisonstest, which disclosed GST±cal cells in a concentration-dependent manner as made
GluR3 at0.75 mg/ml compared to no additions, p , 0.001 as denoted
evident by significant increases of LDH ranging from by *; GST±GluR3 at 1.0 mg/ml compared to no additions, p , 0.001
3- to 5-fold over baseline (one-way analysis of variance as denoted by *; and GST at 1.0 mg/ml compared to no additions,
p . 0.05. The amount of LDH due to LDH present in the plasma[ANOVA], p , 0.0001; Figure 1A). By contrast, filtrates
added at a concentration of 1 mg/ml was less than 4 units/l andfrom seven GST-immunized rabbits and two nonimmu-
did not differ between GST±GluR3 and control. Control wells typi-nized rabbits induced minimal or no increases in LDH
cally have 20±30 units/l of LDH. The amount of protein in the plasma
release (Figure 1A). To confirm the cell-death effect us- of these rabbits was z40 mg/ml; therefore, plasma added at 1 mg/
ing an independent measure, a plasma filtrate from a ml to the media represents a dilution of z1:40.
GST±GluR3 rabbit was shown in each of three experi- (B) An experiment demonstrating that the noncompetitive antago-
nist GYKI 52466 inhibits cell death induced by AMPA (10 mM) butments to induce increased numbers of trypan blue±
not by 1 mg/ml of plasma filtrate from an ill GST±GluR3-immunizedstained cells in comparison to a GST control (data not
rabbit. Bars represent mean 6 standard error of 3±12 wells pershown).
condition. Control (con) wells contained MEM and received only the
To test whether the cell death was excitotoxic, the indicated concentrations of GYKI. Similar results were obtained in
effects of AMPA receptor antagonists were examined. experiments with each of the four GST±GluR3-immunized rabbits
whose plasma filtrates destroyed cortical cells. There was signifi-Cell death induced by AMPA, but not the plasma filtrate,
cant inhibition of AMPA toxicity by GYKI 52466 as compared towas inhibited by a noncompetitive antagonist (GYKI
AMPA in the absence of GYKI 52466 (p , 0.001 as denoted by *,52466) of AMPA receptors (Figure 1B). Likewise, a com-
one-way ANOVA).
petitive antagonist of AMPA and kainate receptors,
6-cyano-7-nitroquinoxaline-2,3-dione (CNQX), inhibited
cell death induced by AMPA but not the plasma filtrate plasma filtrates was examined directly in whole-cell re-
(data not shown). Cell death was not inhibited by either cordings of cultured rat cortical neurons. Plasma fil-
a competitive (100 mM D-APV) or a noncompetitive (MK- trates isolated from the two sick rabbits were applied
801, 1 or 10 mM) antagonist of the N-methyl-D-aspartate to fourteen neurons at a concentration of 1 mg/ml and to
(NMDA) receptor (data not shown); cytotoxicity experi- nine neurons at a concentration of 6 mg/ml; in contrast
ments routinely included 100 mM D-APV to exclude any to robust currents evoked by kainic acid (300 mM) in
LDH release due to NMDA receptor activation. Because each neuron (range, 0.66±13.7 nA; mean, 4.40 nA), no
it is possible that a receptor could be activated by an detectable currents were evoked by plasma filtrate (Fig-
allosteric mechanism insensitive to CNQX or GYKI ure 2). Bath application of cyclothiazide (100 mM), a
compound that inhibits AMPA receptor desensitization,52466, the presence of excitatory properties of these
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Figure 2. Kainate, but Not Plasma Filtrate, Activates Inward Current
in Cortical Neuron
A representative experiment demonstrating the inward current in a
rat cortical neuron in vitro evoked by kainic acid (300 mM) but not
by plasma filtrate (6 mg/ml) isolated from a GST±GluR3-immunized
rabbit. Horizontal bars denote drug or filtrate applications (0.5 s).
Equivalent results were obtained with other preparations of filtrates
and IgG as described in the text.
enhanced the kainic acid response but failed to reveal
any responses to plasma filtrates in five cells tested
(data not shown). Although devoid of detectable excit-
atory properties, cytotoxic effects were readily demon-
strable in other aliquots of these plasma preparations
at concentrations ranging from 0.5±1.0 mg/ml (Figure
1A) and in an aliquot isolated from the same tube con-
taining the sample used for electrophysiologic testing
in Figure 2. To further test for excitatory effects in a Figure 3. IgG and Complement Are Required for Cytotoxicity
more homogeneous population of neurons expressing (A) Representative experiment demonstrating that IgG is necessary
AMPA receptors, the effects of IgG isolated from serum but not sufficient to cause cell death and that the plasma fraction
required to reconstitute the IgG-mediated cell death can be inacti-of the two sick rabbits (see below) were examined in
vated by heat. Cortical cells were incubated with IgG (340 mg/ml)neurons cultured from the rat dentate gyrus; although
isolated by Protein G affinity chromatography and/or filtrate (1.3
responses to kainic acid (range, 72±795 pA; mean, 270 mg/ml) from the Protein G column. Filtrate refers to that portion of
pA) were readily found, no detectable responses to IgG the rabbit plasma that was not retained by the Protein G affinity
(0.2±2.0 mg/ml) were obtained in any of eight neurons column. Heat inactivation was produced by a 30 min incubation at
568C. Heat inactivation eliminated the cell death±producing effectsrecorded in the absence or presence of cyclothiazide
of IgG isolated from each of the four GST±GluR3-immunized rabbits(data not shown). The presence of GluR3 in these cells
whose plasma or serum filtrates destroyed cortical cells.was demonstrated by identification of a band of appro-
(B) Representative experiment demonstrating that addition of sCR1
priate size on an immunoblot prepared from homoge- inhibits lysis of sheep red blood cells (SRBC) as well as the cytotoxic
nates of cultured cortical cells and probed with a peptide effects of rabbit sera on cortical cells in vitro in a concentration-
dependent manner. Lysis was induced by incubating rabbit serumaffinity-purified antibody specific for GluR3 (Wenthold
with SRBC coated with anti-Forssman's antibody; cytotoxic effectset al., 1996; data not shown). As demonstrated in immu-
of the plasma fraction from a GST±GluR3-immunized rabbit werenocytochemical experiments described below, the ma-
measured as in Figure 1A. To facilitate comparison of sCR1 in these
jority of GluR3 in these cultures is present on neurons. two assays, results of each assay were normalized and expressed
The absence of neuroprotective effects of AMPA recep- as percentage of control in absence of sCR1. Values represent
mean 6 SEM of four replicates at each point. Additional experimentstor antagonists, together with the absence of detectable
demonstrated that sCR1 inhibits the cytotoxic effects of the IgGexcitatory effects of the plasma filtrates or IgG, argues
fraction mixed with the filtrate from the Protein G affinity columnthat the mechanism of cell death is not excitotoxic.
(data not shown).
To determine whether the cell death was mediated
by antibodies of the IgG type, the IgG fraction was sepa-
rated from the remainder of the plasma by Protein G (Figure 3A). Mixing the two together, however, reconsti-
affinity chromatography. The effectiveness of the Pro- tuted the cell-death effects, demonstrating that the IgG
tein G column was assessed by probing immunoblots was necessary but not sufficient to produce cell death.
prepared from aliquots of the IgG fraction and Protein The absence of cytotoxic effects of the Protein G filtrate
G filtrate with anti-IgG and anti-IgM antibodies; the vast argues against IgM mediating the cytotoxic effects.
majority of the IgG and IgM was found to reside in the To further characterize the serum antibody response,
IgG fraction and Protein G filtrate, respectively (data the presence and titers of both IgG and IgM antibodies
not shown), thereby demonstrating the selectivity of labeling recombinant TrpE±GluR3 or TrpE itself were
the Protein G chromatography for IgG. In contrast to examined by immunoblotting at dilutions of 1:500 and
the plasma filtrate itself, neither the IgG fraction nor the 1:3000. Serum from each of the five animals immun-
ized with GST±GluR3 exhibited IgG immunoreactivity toProtein G filtrate was sufficient to induce LDH release
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TrpE±GluR3 at a dilution of 1:3000, although the intensity
of the immunoreactivity varied markedlyamong different
animals; none of these sera exhibited immunoreactivity
to TrpE. No immunoreactivity to TrpE±GluR3 was de-
tected in serum of GST-immunized or nonimmunized
animals (data not shown). There was no correlation be-
tween the relative immunoreactivity of the anti-GluR3
IgG measured by immunoblot and either the cytotoxic
effects or the presence of disease among the five GST±
GluR3-immunized rabbits. In contrast to the results of
the anti-GluR3 IgG, only very weak IgM immunoreactiv-
ity to TrpE±GluR3 was detected and only at dilutions of
1:500; this immunoreactivity was present in the serum
of a subset of both GST±GluR3 and GST-immunized
animals (data not shown).
The above results suggested that components of the
filtrate cooperated with the IgG to cause cell death.
To determine whether IgG produced cell death by a
complement-dependent mechanism, the effects of heat
inactivation were examined because of the exquisite
sensitivity of complement to this treatment (Abbas et
al., 1991). Preincubation of the plasma fraction devoid
of IgG at 568C for 30 min eliminated its cytotoxic effects
when mixed with IgG (Figure 3A), a finding consistent
with complement-mediated cytotoxicity. To further as-
sess the potential role of complement, the effects of
soluble complement receptor 1 (sCR1) on plasma fil-
trate±induced celldeath were examined.CR1, a member
Figure 4. Anti-GluR Is Required for Cytotoxicityof the regulator of complement activation family (Weis-
(A) Immunoblots of plasma from GST±GluR3-immunized animal be-man et al., 1990), is a membrane protein expressed on
fore affinity chromatography (left), after preabsorption with GST col-erythrocytes and lymphocytes; it suppresses comple-
umn (center), or after preabsorption with GST±GluR3 column (right).ment activation by reversibly binding to complement
In each panel, the following proteins (approximate molecular
proteins C3b and C4b. sCR1 is a recombinant form of weights in kilodaltons) were loaded into the respective lanes: lane
CR1 lacking the transmembrane and cytoplasmic do- 1, GST protein (26 kDa; denoted by arrows to the left of lane 1) and
lane 2, TrpE±GluR3 (60 kDa; denoted by arrows to the right of lanemains; sCR1 inhibits complement activation in vitro and
2; Rogers et al., 1994). Preabsorption with the GST column is associ-in vivo (Weisman et al., 1990). To monitor the efficacy
ated with marked reduction of IgG-recognizing GST (26 kDa; center,of sCR1, a standard assay for complement lysis was
lane 1) but minimal reduction of IgG-recognizing TrpE±GluR3 (60
employed as described in the Experimental Procedures. kDa; center, lane 2). Preabsorption with the GST-GR3 column is
sCR1 inhibited both complement-dependent lysis of also associated with marked reduction of IgG-recognizing GST (26
sheep red blood cells and the cytotoxic effects of serum kDa; right, lane 1) but, in contrast to the GST column, with virtual
elimination of IgG-recognizing TrpE±GluR3 (60 kDa; right, lane 2).filtrates in cortical cultures in a concentration-depen-
Bands evident in lane 2 that migrate more rapidly than TrpE±GluR3dent manner with similar potencies (Figure 3B). Addi-
likely represent degradation products of TrpE±GluR3, because thesetionally, the reconstitution of cell death using IgG and
are removed by GST±GluR3 affinity column. These immunoblots
Protein G filtrate from a GST±GluR3-immunized rabbit were probed with plasma filtrates from one of four animals subjected
was inhibited by sCR1 (data not shown). to affinity chromatography and presented in experiments in Figure
4B and are representative of results obtained with plasma filtratesTo determine whether the IgG fraction producing the
of all four animals.cell death consisted of anti-GluR IgG in particular, the
(B) LDH release induced by the plasma filtrates of 4 GST±GluR3-effects of selective removal of anti-GST and anti-GluR
immunized rabbits (1 mg/ml) before or after preabsorption with GST
IgG on the cytotoxic effects of plasma filtrate were ex- or GST-GR3 affinity column as shown in immunoblots in (A). Control
amined. Preabsorption of the plasma filtrate with either (CON) refers to LDH released following incubation with MEM. Data
were analyzed by one-way ANOVA followed by post hoc Tukey-a GST±GluR3 (Figure 4A, right, lane 1) or a GST (Figure
Kramer multiple comparisons test, which disclosed plasma com-4A, center, lane 1) affinity column removed the majority
pared to plasma-GR3, p , 0.001 as denoted by ** and plasma-GSTof IgG-recognizing GST. Preabsorption of the plasma
compared to plasma-GR3, p , 0.01 as denoted by *.
filtrate with a GST±GluR3 (Figure 4A, right, lane 2) col-
umn virtually eliminated IgG-recognizing GluR, whereas
preabsorption with a GST (Figure 4A, center, lane 2) effects persisted despite removal of the majority of IgG-
column resulted in minimal reduction of IgG-recognizing recognizing GST. Together with experiments demon-
GluR. The plasma filtrate alone produced robust cyto- strating that IgG is necessary for the cytotoxicity (Figure
toxicity as made evident by a 200% increase of LDH 3A), the elimination of the cytotoxic effects in fractions
release (Figure 4B). The cytotoxic effects were virtually from which IgG-recognizing GluR was selectively re-
abolished in the fraction from which IgG-recognizing moved demonstrates that anti-GluR IgG in particular is
required for the cytotoxic effects of the plasma filtrate.GluR was virtually eliminated, whereas robust cytotoxic
Glutamate Receptor Antibodies and Cell Death
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Figure 5. Antisera Label GluR3- but Not
GluR1- or GluR6-Transfected HEK Cells
Immunocytochemistry of human embryonic
kidney cells transiently transfected with
GluR1 (Figures 5A, 5D, and 5G), GluR3 (Fig-
ures 5B, 5E, and 5H), or GluR6 (Figures 5C,
5F, and 5I). Top panel shows positive controls
in which cells transfected with designated
subunits were incubated with antisera raised
against fusion proteins containing sequences
from analogous portions of GluR1 (Figure 5A)
or GluR6 (Figure 5C); GluR3 (Figure 5B) was
detected with a peptide affinity-purified anti-
body (0.16 mg/ml) raised against peptide con-
taining residues 372±395 of GluR3. Middle
panels show that serum from an ill rabbit with
cytotoxic IgG exhibits immunoreactivity for
GluR3- (Figure 5E) but not GluR1- or GluR6-
transfected (Figures 5D and 5F, respectively)
cells. Bottom panels demonstrate no detect-
able immunoreactivity for any of the subunits
with sera from a GST-immunized rabbit. Unless otherwise specified, all primary antisera were used at a dilution of 1:1000. Methods of detection
using biotinylated anti-rabbit secondary antibodies were followed as previously described (Rogers et al., 1994).
To determine the specificity of the anti-GluR IgG for and the disease was incomplete. Among GST±GluR3-
GluR3 in comparison to other closely related members immunized rabbits, cell death was induced by plasma
of the GluR family, human embryonic kidney cells (HEK GluR3 IgG from the two sick rabbits but also from two
293) transiently expressing GluR1, GluR3, or GluR6 were of three apparently healthy rabbits. If the GluR3 IgG in
examined for immunoreactivity with sera isolated from the peripheral circulation contributes to the disease, it
GST±GluR3-immunized animals. Sera from the three must gain access to GluRs in the central nervous sys-
GST±GluR3-immunized animals exhibiting the most tem. Normally, the blood±brain barrier limits access of
marked cytotoxic effects in the experiments portrayed in circulating IgG to the central nervous system (Brightman
Figure 1A were tested. Labeling of HEK cells transfected et al., 1970), the site of most GluRs. We therefore asked
with GluR3 was readily detected, whereas no labeling whether IgG was detectable in the brains of any of the
of cells transfected with GluR1 or GluR6 was found (Fig- GST±GluR3-immunized or control rabbits. Immunocyto-
ure 5). These findings underscore the specificity of the chemical analyses disclosed the presence of robust
anti-GluR IgG for GluR3 in particular. IgG-like immunoreactivity in neocortex (Figure 6B) and
The finding that anti-GluR3 IgG sera are specific for hippocampus but not thalamus of the two sick rabbits;
GluR3 implies that these cytotoxic antibodies exert their the IgG-like immunoreactivity labeled a subset of neu-
toxic effects by binding to cells expressing GluR3. Since ronal cellbodies in deep cortical layers and their neurites
the cortical cultures contain a diversity of cell types, (Figure 6B). By contrast, IgG-like immunoreactivity was
including neurons and astrocytes, we sought to deter- virtually undetectable in cortex and hippocampus of the
mine the cell type(s) expressing GluR3 in these cultures. three healthy GST±GluR3-immunized rabbits (Figure 6A)
To this end, immunocytochemistry was performed using and in the nine control rabbits (data not shown). Al-
an affinity-purified antibody raised against a peptide though present at low or undetectable levels in cortex,
sequence unique to GluR3 (residues 373±395 as num-
IgG-like immunoreactivity is present in the pia mater of
bered by Keinanen et al., 1990), and the cellular locale
otherwise normal animals (Fabian and Ritchie, 1986;
of the GluR3 immunoreactivity was assessed by coincu-
Schmidt-Kastner et al., 1993) and was evident in allbation with either a neuron- or astrocyte-specific marker
fourteen rabbits studied here (data not shown).(anti-MAP2 [microtubule-associated protein 2] and anti-
To verify that this IgG-like immunoreactivity was in-GFAP [glial fibrillary acidic protein], respectively). These
deed IgG, cryostat sections from ill and healthy GST±double-labeling experiments revealed that the vast ma-
GluR3-immunized rabbits were homogenized and ana-jority of cells labeled with anti-GluR3 were also labeled
lyzed by PAGE. Immunoblots (Figure 7A) probed withwith anti-MAP2 but not with anti-GFAP (data not shown).
an affinity-purified antiserum raised against rabbit IgGOnly a minority of cells labeled with anti-GluR3 were
demonstrated increased labeling of a 50 kDa band inlabeled with anti-GFAP, and such cells were lightly la-
cortical homogenates from a sick GST±GluR3-immu-beled (data not shown). These findings are consistent
nized rabbit (Figure 7A, lane 2) in comparison toa healthywith previous findings of Eshhar et al. (1993) and indicate
GST±GluR3 animal (Figure 7A, lane 3). The similarity inthat the majority of GluR3 expressed in these culture
size to pure IgG (Figure 7A, lane 1) suggests that thisconditions resides on neurons.
50 kDa band is the heavy chain of IgG and, togetherThe deleterious effects of plasma-derived GluR3 IgG
with the immunocytochemical results, supports the ideaon cortical cells in vitro suggested that GluR3 IgG in the
that increased amounts of IgG are present in the brainssystemic circulation might contribute to the neurological
of the sick rabbits. No IgM was detectable in corticaldisease observed in two of the rabbits in vivo. However,
the correlation between the deleterious effects in vitro homogenates of any of these animals as assessed by
Neuron
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Figure 6. Immunohistochemistry of Rabbit and Human Cortex
(A and B) Staining of brain samples from healthy and sick GST±
GluR3-immunized rabbits using an anti-rabbit IgG antibody
(1:60,000).
(A) No cellular labeling was seen in the brains of healthy rabbits.
Figure 7. Immunoblots Disclose Increased IgG and anti-GluR3 inRed blood cells (closed arrowhead) present in capillaries were
Cortical Homogenates of Ill Rabbitsstained due to endogenous peroxidase activity; the pial surfaces of
(A) To confirm the presence of increased IgG immunoreactivity inthese brains were also labeled (data not shown), as has been re-
the cortex of an ill GST±GluR3-immunized rabbit compared to aported previously (Fabian and Ritchie, 1986).
healthy GST±GluR3-immunized rabbit, 200 mg aliquots of homoge-(B) By contrast, a subset of neurons in deep cortical layers (shown)
nates of six 30 mm sections of cortex were subjected to PAGE andand hippocampi (data not shown)of the sick rabbits was prominently
immunoblots were incubated with the anti-rabbit IgG antisera usedlabeled (open arrow). Note staining of the apical dendrites of these
for immunohistochemistry (lanes 1, 2, and 3). Lane 1 contains 0.1neurons (open arrowhead). In control experiments, omission of the
mg purified rabbit IgG; extracts are from cortical sections of an illanti-rabbit IgG antibody eliminated all labeling.
(lane 2) or healthy (lane 3) GST±GluR3-immunized rabbit; note the(C±F) Staining of brain samples from patients with RE and complex
greater immunoreactive labeling of the band (arrow) approximatingpartial epilepsy using antibodies directed at human IgG (1:1000, [C]
50 kDa (which likely corresponds to the heavy chain of IgG) fromand [D]) and MAC (1:2000, [E] and [F]).
the ill (lane 2) compared to the healthy (lane 3) rabbit. To control for(C and E) Images of the staining obtained with one of the complex
loading and transfer, this blot was stripped and reprobed with anpartial epilepsy patients, representative of the group of patients
antibody to b actin (lanes 4, 5, and 6), which showed similar immuno-lacking neuronal labeling with these antibodies (one RE and three
reactive labeling (arrow) for the ill (lane 5) and healthy (lane 6) rabbits.complex partial epilepsy cases). Anti-IgG (C) and anti-MAC (E) la-
(B) To test for the presence of anti-GluR3 in rabbit brain, TrpE±GluR3beled only capillaries (closed arrowheads), presumably reflecting,
and TrpE (data not shown) were subjected to PAGE, transferred torespectively, the presence of circulating human immunoglobulins
Immobilon, and incubated with extracts from homogenized cryostatand nascent MACs that may have formed prior to fixation of tissue.
brain sections of an ill GST±GluR3- and a healthy GST±GluR3-immu-(D and F) Representative photographs of sections from one of the
nized rabbit. IgG was detected by incubation of the blot with 125I-two RE samples demonstrating positive neuronal labeling with anti-
Protein A followed by autoradiography; note the presence of in-human IgG (D) or anti-MAC (F) antibodies. Identical patterns of label-
creased immunoreactive labeling of TrpE±GluR3 with the extracting were obtained with each antibody, including robust staining of
from the ill (lane 1) compared to the healthy (lane 2) rabbit. To controlneurons (open arrows) and their apical dendrites (open arrowheads).
for loading and transfer, this blot was stripped and reprobed with aEach antibody labeled subsets of neurons in discrete patches scat-
peptide affinity-purified antibody specific to GluR3; immunoreactivetered about the sections, and the domains stained by the anti-MAC
bands of similar intensity with size approximating 60 kDa were foundantibody generally overlapped with those labeled by the anti-IgG
for the lanes probed from the ill (lane 3) and healthy (lane 4) rabbits.antibody. Capillaries were darkly stained as well (closed arrow-
The absence of immunoreactive labeling of TrpE detected in anheads). Omission of the primary antibody or preincubation of the
immunoblot with the cortical homogenate from the ill GST±GluR3primary with the antigen against which it was raised, but not an
rabbit (data not shown) demonstrates that the immunoreactivity inirrelevant protein, abolished all cellular and the majority of capillary
lane 1 is directed to GluR3.labeling, confirming specificity of the staining shown here. Scale
bar in (A) is 50 mm and pertains to all photographs. The top of each
photo is parallel to the pial surface.
rank order correlation test; this analysis revealed a sig-
nificant association (p , 0.0005) between the two vari-
ables.stripping and reprobing this immunoblot with an anti-
IgM (data not shown). The strength of association be- To determine whether the IgG included anti-GluR3
IgG, immunoblots with both TrpE and TrpE±GluR3 weretween the neurological disease and the presence of
increased amounts of IgG in the cortex was measured incubated with extracts of cortical homogenates iso-
lated from a sick and a healthy GST±GluR3-immunizedwith a nonparametric test of association, the Spearman
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rabbit; the presence of immunoreactivity for TrpE±GluR3 neurological disorder characterized by epileptic sei-
but not TrpE (TrpE not shown) in the GST±GluR3 cortical zures and motor incoordination. Second, anti-GluR3
homogenates (Figure 7B, lane 1) demonstrates the pres- isolated from GST±GluR3-immunized rabbits promoted
ence of increased amounts of anti-GluR3 IgG in the death of cortical neurons in vitro by a complement-
brain of the sick compared to the healthy GST±GluR3- dependent, but not excitotoxic, mechanism. Third, the
immunized rabbit. subset of GST±GluR3-immunized rabbits with the neuro-
The presence of robust IgG immunoreactive labeling logical disorder exhibited abundant IgG immunoreactiv-
of neurons in the cortex of sick but not healthy rabbits ity decorating neurons and their processes in neocortex
led us to query whether similar evidence of neuronal and hippocampus. Fourth, a subset of patients with RE
IgG deposition was detectable in humans with RE. Addi- exhibited both IgG-like and MAC-like immunoreactivity
tionally, the availability of antibodies directed against decorating neurons and their processes in cortex.
components of the human complement system permit- The present results confirm and extend our original
ted a search for evidence of complement activation with findings (Rogers et al., 1994), in that epileptic seizures
an antibody directed against the MAC; the lack of re- and inflammatory cell infiltrates were evident in two of
agents effective for immunohistochemical labeling of five rabbits immunized with a GST±GluR3 fusion protein
rabbit complement proteins in our hands precluded (including residues 246±455) that closely resembles the
analogous studies of rabbit brain. Immunohistochemis- GluR3 sequence of the TrpE±GluR3 protein (residues
try using antibodies against IgG and MAC was per- 246±458) used in the initial study. This neurological syn-
formed in parallel on 30 mm sections of cortex surgically drome is almost certainly triggered by the GluR3 protein
resected from three RE and three complex partial epi- itself, because a similar syndrome did not occur in any
lepsy cases and from cortex obtained at autopsy from of seven controls immunized with GST alone; moreover,
one Alzheimer's disease (AD) patient. The AD tissue eliciting the same syndrome with distinct bacterial pro-
served as a positive control, as several investigators teins (TrpE in the original study and GST in the present
have found complement (but not IgG) deposition in the study) fused to GluR3 underscores the pivotal nature
brains of AD patients (e.g., McGeer et al., 1989), an of GluR3. The absence of this distinctive neurological
observation confirmed in the present study (data not syndrome in more than 50 rabbits immunized with TrpE
shown). The complex partial epilepsy samples served fusion proteins containing GluR1, GluR2, GluR5, or GluR6
as negative controls. Staining with both the anti-IgG or neuronal nicotinic acetylcholine receptor (nAChR)
and anti-MAC antibodies revealed robust labeling of subunits in our initial study (Rogers et al. 1994) suggests
neuronal cell bodies and apparent apical dendrites in that sequences unique to GluR3 are critical, a sugges-
two of the three RE cases studied (Figures 6D and 6F, tion to be further tested in future studies. The abnormali-
respectively). Staining with each antibody typically la- ties in these rabbits recapitulate several features of RE,
beled the perimeter of the cell body and excluded the including epileptic seizures, inflammatory histopathol-
nucleus; however, staining of nuclei was evident in a ogy, and selectivity of theanti-GluR antibodies for GluR3
subset of apparent neurons that exhibited a shrunken but not the closely related subunits GluR1 or GluR6. The
pyknotic appearance. Cellular staining of the RE brains disorder in the rabbits differs from RE in the absence
was detected on subsets of neurons contained within of overt weakness or unilateral neurologic deficit and in
discrete areas of z300±2000 mm scattered about the the bihemispheric distribution of the inflammatory cell
sections; this multifocal pattern is similar to previous infiltrates. The features common to these disorders pro-
descriptions of neuronal loss and inflammatory cell infil- vide hope that study of the rabbits will facilitate insights
trates in RE brains (Farrell et al., 1995). Importantly, each into the pathogenesis of the disease in humans.
antibody labeled neurons in apparently overlapping The responsiveness of patients with RE to plasma
patches of adjacent or nearby sections. In contrast to
exchange (Rogers et al., 1994; Andrews et al., 1996)
these findings, no distinct cellular labeling was noted
that removed circulating anti-GluR3 (Rogers et al., 1994)
with either the anti-IgG or anti-MAC antibodies in one
suggested that these antibodies may contribute to the
of the three RE cases or in any of three complex partial
progressive neuronal loss and hemispheric atrophy of
epilepsy cases (Figures 6C and 6E, respectively). Omis-
this disease. Glutamate receptors are pivotally involvedsion of the primary antibody eliminated distinct cellular
in excitotoxicity, a mechanism of cell death in the mam-labeling in all samples. Preincubation with the proteins
malian central nervous system whereby excessive acti-against which the antibodies were raised (human IgG
vation of these receptors by glutamate can destroy cellsand soluble MAC for anti-IgG and anti-MAC, respec-
(Choi, 1988). The report that anti-GluR3 antibodies iso-tively) also eliminated distinct cellular labeling and the
lated from the ill TrpE±GluR3-immunized rabbits and twomajority of capillary staining, whereas preincubation
patients with RE can activate CNQX-sensitive currents inwith irrelevant proteins (rabbit IgG and C4, respectively)
cortical neurons (Twyman et al., 1995) raised the possi-did not affect staining of cells or capillaries (data not
bility that the antibodies may destroy cells through anshown). Together, these control experiments support
excitotoxic mechanism. Despite replicating the neuro-the specificity of staining observed with these anti-
logical disorder observed in our initial report, no evi-bodies.
dence of any currents activated by either filtered plasma
or IgG isolated from serum of the ill rabbits was de-
tected in recordings from cortical or dentate gyrus neu-Discussion
rons in the present study. Multiple differences exist be-
tween the experimental protocols of Twyman et al.Four principal findings emerge from this work. First, a
subset of GST±GluR3-immunized rabbits developed a (1995) and the present study, including (1) the neurons
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studied (E14±E16 mouse cortex studied at 4±6 weeks GluR6 disclosed immunoreactivity to GluR3- but not
in vitro versus E18 rat cortex studied at 2±3 weeks in GluR1- or GluR6-transfected cells. The lack of correla-
vitro or P4 rat dentate gyrus studied at 9±11 days in tion between anti-GluR antibody titers measured by im-
vitro), (2) the fusion protein used for immunization (TrpE± munoblot and either cytotoxic effects of antisera or dis-
GluR3 246±458 versus GST±GluR3 246±455), (3) the ease in the present study is paralleled by similar findings
method of removal of low molecular weight substances in an autoimmune disease in which anti-receptor anti-
(repeated filtration through an Amicon Microcon filter bodies are pivotal in pathogenesis, namely myasthenia
versus Sephadex G50 chromatography), and (4) the gravis. That is, the presence, but not the titers, of anti-
product used for isolation of IgG (protein G sepharose acetylcholine receptor antibodies correlates with illness
from Pharmacia versus protein G agarose from Pierce). in both human myasthenia gravis and experimental au-
It is possible, for example, that our methods for removal toimmune myasthenia gravis (Christadoss et al., 1985;
of low molecular weight substances could have elimi- Drachman, 1994). Whether this lack of correlation is due
nated a light or heavy chain of the GluR3 antibody con- to the ability of subpopulations of anti-GluR3 to bind
taining agonist properties. Likewise, if our cultures con- and/or activate complement is uncertain.
tained increased numbers of astrocytes available to The assertion of a complement-dependent mecha-
buffer glutamate released from dying neurons, this could nism in the present study is based upon two observa-
obscure detection of a GluR3 antibody with excitotoxic tions. First, the activity of the rabbit plasma fraction
properties; nevertheless, this latter possibility would not required to reconstitute the cell-death effects of the
be expected to obscure detection of a GluR3 antibody IgG can be destroyed by heating to 568C for 30 min,
with agonist properties in the whole-cell recordings. a treatment known to inactivate complement. Second,
Twyman et al. (1995) reported using filtrates or IgG iso- sCR1 inhibited the cell death±inducing effects of serum
lated from serum; we have obtained equivalent results filtrate as well as theProtein G fraction required to recon-
in both cytotoxicity and electrophysiologic assays using stitute the cytotoxic effects of IgG. The similarity in the
filtrates of plasma and serum. These various factors potency of inhibitory effects of sCR1 on lysis of sheep
notwithstanding, we suspect that the specificity of the erythrocytes and the cytotoxic effects of rabbit sera on
immune response mounted to the GluR3 antigen in the cortical cells strengthens the likelihood that the mecha-
different rabbits is the most likely explanation for these nism of the sCR1 effect involves inhibition of comple-
divergent results. Consistent with heterogeneity of the
ment. Antibody-dependent destruction of cells through
immune response is the observation in this study that
binding and activating complement has rich precedent
serum isolated from one of five GST±GluR3-immunized
in many nervous system diseases, including experimen-
rabbits did not contain cytotoxic antibodies, despite
tal allergic encephalomyelitis and potentially multiple
exhibiting abundant anti-GluR3 IgG when titered using
sclerosis and Guillain-Barre syndrome (Morgan, 1993).
immunoblots (data not shown). Regardless of the fac-
Moreover, circumstantial evidence for a complement-tor(s) underlying the differences in electrophysiologic
dependent mechanism of cell injury by antibodies di-results, the absence of antibody-activated CNQX-sensi-
rected against a ligand-gated ion channel receptor hastive currents, together with the insensitivity of the anti-
emerged from study of myasthenia gravis; immunocyto-GluR3-mediated injury to ionotropic glutamate receptor
chemical evidence of both IgG (Engel et al., 1979) andantagonists, argues against an excitotoxic mechanism
the MAC of complement (Engel and Arahata, 1987) atof GluR3 IgG±mediated cytotoxicity in the present study.
the neuromuscular junction suggests that anti-AChR an-Instead, our findings implicate a heretofore unde-
tibodies damage the postsynaptic membrane at leastscribed mechanism of glutamate receptor-dependent
in part through a complement-dependent mechanism.cell death. We propose that anti-GluR3 IgG binds GluR3
Given the predominant localization of GluR3 to neuronson rat cortical cells in vitro and triggers death by a
in the mixed cortical cultures studied here, it seemscomplement-dependent mechanism. The assertion that
plausible that the anti-GluR3 IgG binds GluR3 on cor-this is IgG is based upon the selectivity of the Protein
tical neurons and activates the complement cascade;G affinity chromatography together with experiments
whether the cytotoxicity reflects lysis caused by MACdemonstrating that the IgG fraction is necessary but not
formation on these same neurons or an indirect mecha-sufficient for the cytotoxicity. The assertion that this is
nism involving other cell types is a topic for future study.GluR IgG rests upon the demonstration that the cyto-
The presence of circulating antibodies to GluR3 intoxic effects of the plasma are virtually abolished in
the serum of patients with active RE and the clinicalfractions from which anti-GluR IgG has been virtually
improvement paralleling reduction of the antibody titerseliminated by affinity chromatography; by contrast, ro-
led us (Rogers et al., 1994; Andrews et al., 1996) tobust cytotoxic effects of plasma persist despite selec-
suggest that the antibodies themselves may damagetive removal of the majority of anti-GST IgG. Whether
the nervous system. For this suggestion to be correct,affinity-purified anti-GluR IgG eluted from these col-
the antibodies must have deleterious properties andumns combined with a source of complement could fully
must gain access to the antigen. Since access of circu-reconstitute the cytotoxic effects is uncertain; neverthe-
lating IgG to antigens in the central nervous system isless, the virtual elimination of the cytotoxicity following
normally limited by the blood±brain barrier, we postu-selective removal of anti-GluR IgG implicates anti-GluR
lated that the blood±brain barrier must somehow beIgG as the predominant complement-activating IgG in
disrupted in RE to account for the response to plasmathis phenomenon. The assertion that this is anti-GluR3
exchange. The present findings demonstrate that IgGIgG in particular rests upon the fact that immunocyto-
has gained access to neuronal epitopes in the brain, inchemical study of HEK cells transfected with single sub-
units of the closely related proteins GluR1, GluR3, and that abundant IgG-like immunoreactivity was evident
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Freund's adjuvant, with subsequent injections in incompleteover a subset of neuronal cellbodies and their processes
Freund's adjuvant. The first boost was given 2 weeks after the initialin deep layers of cortex in each of the two ill rabbits
immunization, and the remaining boosts were given at 4 week inter-but not in any control rabbits or healthy GST±GluR3-
vals. Plasma was obtained by collecting blood in sodium heparin
immunized rabbits (all of which, nevertheless, had ro- (1000 units/ml).
bust immune responses to GluR3). Increased IgG-like Sephadex G-50 chromatography was used to reduce the concen-
tration of glutamate and other small molecular weight substancesimmunoreactivity was also evident in hippocampus but
in plasma. The plasma was diluted 1:1 in Hank's Balanced Saltnot in thalamus or cerebellum of the ill rabbits. The
Solution (HBSS)/HEPES and passed over Sephadex G-50 (Phar-distribution of the IgG-like immunoreactivity revealed by
macia) columns twice; in initial experiments, this procedure removedimmunocytochemistry is similar to that of GluR3 expres-
.99% of free glutamate as demonstrated by monitoring 3H-gluta-
sion as detected by in situ hybridization of mature rat mate added to the plasma. IgG was purified with Protein G agarose
brain (Keinanen et al., 1990). (Pierce) affinity chromatography using 100 mM glycine-HCl (pH 2.5)
for elution according to the manufacturer's instructions. The elutedThese immunohistochemical findings led to our dem-
immunoglobulin fraction was concentrated and equilibrated withonstration of analogous findings in the brains of two of
HBSS/HEPES using centrifugal concentrators (Centricon 50, Ami-three patients with RE; that is, neuronsÐin particular,
con); the fraction exceeding 50 kDa was retained and stored at 48Ctheir cell bodies and apparent apical dendritesÐexhibited
until use. In some experiments, the non-IgG portion of plasma was
IgG-like labeling in a pattern with striking similarity to also collected, concentrated and equilibrated with HBSS/HEPES.
that of the rabbits. Precisely how the IgG and members Protein concentrations were determined by modified Bradford
protein assay (Coomassie Plus, Pierce). The plasma and portion ofof the complement cascade gained access to the neu-
plasma not retained by Protein G agarose columns were filtered,rons is uncertain, but the paucity of detectable B cells
aliquoted, and stored at 2808C.in histochemical studies of brains of RE (Farrell et al.,
1995) patients strengthens the likelihood that circulating
Preabsorption and ImmunoblotIgG gained access through a defect in the blood±brain
Antibodies to GST and GST±GluR3 were removed from plasma by
barrier, a suggestion consistent with the responsiveness affinity chromatography with GST or GST±GluR3 bound to glutathi-
of some of these patients to plasma exchange. We are one-sepharose 4B. GST or GST±GluR3 was mixed with glutathione-
sepharose 4B at a concentration of 1 mg protein/ml resin. Plasmaattempting to test this idea by determining whether focal
was incubated (plasma:resin, 2:1, vol/vol) with gentle agitation at 48Cdisruption of the blood±brain barrier in an asymptomatic
for 16 hr and centrifuged, and the supernatant (either GST±GluR3 oranimal with circulating cytotoxic anti-GluR3 will induce
GST-absorbed plasma) was used for subsequent experiments. Tofocal encephalitis and seizures.
test the efficacy and specificity of preadsorption, TrpE±GluR3 (Rog-
The availability of anti-MAC antibodies useful for hu- ers et al., 1994), GST±GluR3, GST, and rat-brain membranes were
man study permitted detection of anti-MAC±like labeling subjected to SDS-PAGE and transferred to Immobilon-P (Millipore)
by electroblotting (100 V, 1 hr at 48C). After fixation in methanol andof neuronal cell bodies and processes in the same re-
acetic acid, the blot was blocked with 5% nonfat dry milk and 0.1%gions of cortex demonstrating IgG-like labeling. The
Tween 20 in 13 phosphate buffered saline (PBS) for 1 hr and thenpresence of anti-MAC±like labeling provides evidence
incubated for 1 hr in plasma diluted 1:1000 in blocking buffer. Afterfor activation of the complement cascade, resulting in
washing for 15 min with three intermediate changes, blots were
deposition of potentially cytolytic MAC on these neu- incubated with horseradish peroxidase-conjugated donkey anti-
rons. Moreover, the fact that neurons in overlapping rabbit Ig (1:5000, Amersham) for 1 hr. Following several washes with
0.1% Tween 20 in 13 PBS, immunoreactivity was visualized with theareas of adjacent or nearby sections were labeled by
enhanced chemiluminescence (ECL) detection system (Amersham).each antibody raises the possibility that the anti-neu-
For detection of IgG in rabbit brain by immunoblotting, 30 mm cryo-ronal IgG triggered activation of the complement cas-
stat sections of cortex (near those depicted in Figure 6B) werecade. The presence of MAC-like immunoreactivity on
homogenized in 13 PBS, subjected to PAGE, transferred to Immobi-
these neurons may provide an important clue to the lon-P, and probed with goat anti-rabbit IgG (Jackson Lab, 1:10,000).
pathogenesis of the neuronal degeneration and seizures For detection of IgM, the blot was stripped in 0.25 M glycine buffer
pH 2.5 in 0.05% Tween 20 and reprobed with goat anti-rabbit IgMof RE.
(Southern Biotech, 1:5000).
To detect the presence and relative amount of GluR3 antibodies,
Experimental Procedures TrpE and TrpE±GluR3 were subjected to SDS-PAGE and transferred
to Immobilon-P as described in the preceding paragraph, blocked
Construction of Plasmid and Purification of Fusion Protein with 5% dry milk, probed by rabbit sera (1:500 and 1:3000), and then
GluR3 protein was expressed as a fusion protein linked to GST using incubated with goat-anti-rabbit IgG or IgM (Jackson Lab, 1:5000).
the GST bacterial expression system (Pharmacia). A BamHI-SmaI
restriction fragment encoding a portion of the N-terminal extracellu- Tissue Culture
lar domain (residues 246±455) of rat GluR3 was subcloned into a Mixed neuronal andglial cultures were preparedfrom embryonic day
pGEX-KT vector and used to transform E. coli. The GST protein was 18 rat cerebral cortices (Sprague-Dawley, Zivic Miller) as previously
obtained by transforming bacteria with the pGEX-KT vector itself.
described (Patel et al., 1996). In brief, the cerebral cortices were
The GST±GluR3 fusion protein was purified using SDS-PAGE and
dissected and enzymatically dissociated by incubation in Ca21- and
visualized by soaking the gel in 0.3 M CuCl2 for 10 min. GST protein Mg21-free HBSS supplemented with 10 mM HEPES and 0.25% tryp-
was purified either as describedfor GST±GluR3or using glutathione-
sin for 20 min at 378C. The tissue was rinsed and dispersed into
sepharose 4B according to the manufacturer's protocol; equivalent
single-cell suspension by gentle passage through a fire-polished
results were obtained with animals immunized with GST prepared
Pasteur pipette. The cell suspension was centrifuged and resus-
by either method. Purified proteins were aliquoted and frozen at pended in Minimum Essential Media (MEM) containing Earle's salts
2808C until use. supplemented with 3 g/l glucose, 5% horse serum, and 5% fetal
bovine serum (growth medium). The cells were plated at a density
of 400,000±500,000 cells/well in poly-D-lysine±coated 24-well platesAntibody Production, Preparation of Plasma,
and Purification of IgG and maintained at 378C in a humidified incubator with 5% CO2/95%
O2 in growth medium. Medium was not replaced so as to reduceWhite New Zealand male rabbits weighing 2.5 kg were injected
subcutaneously with 100 mg GST±GluR3 or GST in complete glial overgrowth and neuronal loss. Mature cells (2±3 weeks in vitro)
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were used for all experiments. Dentate gyrus cells were prepared AD was fixed for one month in 2.5% paraformaldehyde/0.2% glutar-
aldehyde at 48C in 13 PB. Blocks were then cryopreserved in 20%as described previously (Lerea et al., 1992). Poly-D-lysine coated
coverslips were maintained for 9±11 days prior to electrophysiology sucrose in 13 PB and frozen in isopentane chilled in a dry ice/
methanol bath. Thirty micrometer frozen sections were collected inexperiments in a humidified incubator at 378C in 95% O2/5% CO2.
For the assessment of cell death in cortical cultures, the growth 24-well culture plates containing 13 PBS and stored at 48C until
use. For the immunohistochemistry, sections from the RE, complexmedium was replaced with MEM and cells incubated with various
treatments for 24 hr at 378C. One hundred mM D-APV was routinely partial epilepsy, and AD cases were processed in parallel; all
blocking, staining, and washing of sections was carried out in aincluded to block NMDA receptor activation, except in the initial
experiments in which the effect of APV was monitored. Receptor 24-well tissue culture plate at room temperature, unless otherwise
specified.antagonists were added 15 min prior to AMPA or plasma filtrates.
Neurotoxicity was determined by the measurement of LDH released To block endogenous peroxidase activity, floating sections were
incubated for 30 min in 0.3% H2O2 in 13 PBS. Following two washesinto the supernatant media as previously described (Patel et al.,
in 13 PBS, sections were incubated for 1 hr in blocking buffer (131996). LDH was measured by the method of Vassault (1983) using
PBS containing 0.1% Triton X-100, 2% bovine serum albumin, andan ultraviolet automated plate reader (Molecular Devices). In some
2% donkey serum) to reduce nonspecific background staining. Dur-experiments, cell death was also monitored by uptake of trypan
ing these treatments, the primary antibody (Jackson Immuno Re-blue as previously described (Patel et al., 1996). To inactivate com-
search affinity-purified biotinylated anti-human IgG, 1:1000 or Cal-plement in the plasma or serum, samples were heated in a 568C
biochem anti-MAC, 1:2000) was preadsorbed for 3 hr at roomwater bath for 30 min prior to incubation with cells. Alternately, cells
temperature in blocking buffer containing 20 mg/ml rat-brain proteinwere incubated with serum fractions in the presence of varying
prepared by acetone extraction (Harlow andLane, 1988). The dilutedconcentrations of sCR1 (Weisman et al., 1990).
primary antibody was subsequently spun briefly in a microfuge and
the supernatant applied directly to the tissue sections. In some
Hemolytic Assay experiments, the antibody was incubated for an additional 3 hr at
To verify functionality of the sCR1, hemolytic assays were performed room temperature with 62 mg/ml of either the protein against which
according to standard procedures (Kabat and Mayer, 1961). Briefly, the antibody was raised (e.g., purified human IgG [Jackson Immu-
sheep red blood cells suspended in Veronal-buffered saline (VBS noresearch] or soluble MAC [Advanced Research Technologies]) or
[in mM]: 145 NaCl, 3.1 barbital, 1.8 Na barbital, 1 MgCl2, and 150 an irrelevant protein (e.g., purified rabbit IgG [Cappell] or C4 protein
mM CaCl2) were coated with anti-Forssman's antibody (kindly pro- [Quidel], respectively). After the additional 3 hr incubation, the prein-
vided by Dr. Michael Frank, Duke University) for 15 min at 308C. cubated primary antibody mix was applied to the tissue sections.
After washing, coated red blood cells were exposed to rabbit serum The sections were incubated for 1 hr at room temperature and then
either with or without various concentrations of sCR1 for 60 min at 36 hr at 48C. After this, the sections incubated with anti-MAC were
378C. Hemolysis reactions were stopped with the addition of ice- washed three times in blocking buffer and transferred to wells con-
cold divalent-free VBS, the mixtures were centrifuged, and hemoly- taining secondary antibody (Jackson Immuno Research affinity-
sis was quantitated by measurement of the absorbanceof thesuper- purified biotinylated anti-rabbit IgG, diluted 1:400 in blocking buffer).
natant at 412 nm. Exclusion of either antibody or rabbit serum from One hour later, all sections were washed three times in 13 PBS
the assay eliminated the hemolysis (data not shown). containing 0.1% Triton X-100 and 2% bovine serum albumin; follow-
ing this, the sections were incubated with Vectastain ABC reagent
for 1 hr. Color development was allowed to proceed for 5 min in aImmunohistochemistry of Rabbit Brains
substrate solution composed of 0.001% H2O2, 0.25 mg/ml DAB,Rabbits were deeply anesthetized with pentobarbital (45 mg/kg i.p.)
and 6.25 mg/ml NiSO4 in 0.175 M sodium acetate. Sections wereor ketamine/xylazine (50 mg/kg/10 mg/kg i.m.) and perfused trans-
mounted on gelatin-coated slides, air dried, dehydrated in gradedcardially with 500 ml of 0.9% NaCl followed by 1 liter of 4% parafor-
alcohols, and coverslipped with Permount. Patterns of staining inmaldehyde in 0.1 M sodium phosphate buffer (13 PB [pH 7.4]) or 1
these sections were ascertained by an investigator (J. O. M.) blindedliter of 3% glutaraldehyde in 13 PBS at a rate of 75 ml/min. Blood
to patient diagnosis, primary antibody, and preincubation protocol.(100 ml) was collected from each rabbit prior to saline perfusion.
The brain was incubated in fixative overnight and cryoprotected in
Immunocytochemistry of Transfected HEK Cells30% sucrose in 13 PB. The brain was divided in the sagittal plane
Human embryonic kidney (HEK) 293 cells were transfected withinto two hemispheres. The right hemisphere was kept whole and
expression plasmids containing either GluR1, GluR3, or GluR6 byfrozen while the left hemisphere was divided into four coronal
the calcium phosphate method as described previously (Rogers, etpieces, each of which was frozen in isopentane chilled in a dry ice/
al., 1994). Forty-eight hours after transfection, cells were fixed formethanol bath. Thirty micrometer frozen sections were collected in
30 min at 48C in PBS containing 4% paraformaldehyde, washed24-well culture plates containing 13 PBS and stored at 48C until
twice in 13 PBS, and incubated in blocking solution (PBS containinguse.
2% horse serum, 0.5% BSA, 0.05% Tween-20, and 0.05% TritonAll immunohistochemistry steps were carried out at room temper-
X-100) for 1 hr followed by an overnight incubation at 48C withature. To reduce nonspecific binding of antibody, sections were
primary antibodies diluted in blocking solution. The next day, cellsblocked with 10% donkey serum in 13 PBS for 1 hr and incubated
were washed four times in blocking solution and incubated for 1 hrin secondary antibody (Jackson Immuno Research affinity-purified
at room temperature with anti-rabbit IgG (1:200, Vector Labs) inbiotinylated donkey anti-rabbit IgG, 1:60000) in 13 PBS containing
blocking solution. Next they were washed four times in 13 PBS and2% BSA for 2 hr followed by three 10 min washes in 13 PBS and
incubated for 1 hr at room temperature with Vectastain Elite ABC2% BSA. Sections were treated with Vectastain ABC reagent (Vector
reagent prepared according to the manufacturer's instructions (Vec-Labs) and developed with 3,39-diaminobenzidine tetrahydrochloride
tor Labs). The ABC reagent was removed with four washes in 13(DAB) as the chromogen. To reduce background, sections were
PBS and the cells reacted with DAB solution prepared in 13 PBSpreincubated in DAB alone for 5 min. Sections were mounted in 13
to which 0.3% H2O2 had been added immediately before exposurePBS on gelatin-coated slides, air dried, rinsed in water, dehydrated
to cells. After 3±5 min, cells were washed four times with PBS andin ethanol, cleared in xylene, and coverslipped with Permount. Con-
maintained in PBS. Antisera used for positive controls for GluR1
trols included sections from nonimmunized rabbits as well as sec-
and GluR6 were obtained from Dr. Scott Rogers as described by
tions not treated with secondary antibody.
Rogers et al. (1994); antisera used as a positive control for GluR3
were raised against amino acids 373±395 of GluR3 as numbered by
Immunohistochemistry of Human Brain Samples Keinanen et al. (1990) and affinity purified. Sera from GST- and
Surgically resected cortical tissue from three RE and three complex GST±GluR3-immunized rabbits were used at a 1:1000 dilution.
partial epilepsy patients was cut into blocks z0.5±1.0 cm thick and
immersion fixed at 48C either for 72 hr in 2.5% paraformaldehyde/ Electrophysiology
0.2% glutaraldehyde or for 1 week in 4% paraformaldehyde in 13 Whole-cell recordings were obtained at room temperature from cells
having a neuronal morphology with an Axoclamp-2A amplifierPB. Positive control tissue obtained at autopsy from a patient with
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equipped with a HS-2A x0.lL headstage, both from Axon Instru- Keinanen, K., Wisden, W., Sommer, B., Werner, P., Herb, A., Ver-
doorn, T.A., Sakmann, B., and Seeburg, P.H. (1990). A family ofments. Cells were continuously perfused at 1 ml/min with a bath
consisting of (in mM) 119 NaCl, 5 KCl, 2 CaCl2, 2 MgCl2, 30 glucose, AMPA-selective glutamate receptors. Science 249, 556±560.
and 25 HEPES (pH 7.4) equilibrated with 95% O2/5% CO2. For drug Lerea, L.S., Butler, L.S., and McNamara, J.O. (1992). NMDA and
delivery, an array of blunt micropipettes z20 mm in diameter was non-NMDA receptor-mediated increase of c-fos mRNA in dentate
positioned about 100 mm from the cell. Drugs were ejected by 0.5± gyrus neurons involves calcium influx via different routes. J. Neu-
2.0 s pressure ejection from a Picospritzer II (General Valve). Re- rosci. 12, 2973±2981.
cording electrodes having resistances of 2±4 MV were filled with a McGeer, P.L., Akiyama, H., Itagaki, S., and McGeer, E.G. (1989).
recording buffer of (in mM) 112 D-gluconic acid (2,3,4,5,6-pentahy- Immune system response in Alzheimer's disease. Can. J. Neurol.
droxy caproic acid), 17.5 CsCl, 49 HEPES, 2 EGTA, 3 MgCl2, and 2 Sci. 16, 516±527.
Na2ATP (pH 7.2).
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